»Ê¼Ò»ªÈË
Close
Study
Research
Engage
About
Give
»Ê¼Ò»ªÈËews
Home
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
»Ê¼Ò»ªÈËews
Improved metrics for Huntington's disease trials
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
Home
Latest news
UCL in the media
Services for media
Student news
Staff news
Tell us your story
Contact us
»Ê¼Ò»ªÈËews
Improved metrics for Huntington's disease trials
Improved metrics for Huntington's disease trials
4 June 2018
Professor Sarah Tabrizi (UCL Institute of Neurology) says we're in a 'new era' of Huntington's disease clinical trials, and discusses the drug trial with Ionis Pharmaceuticals that she finalised this year. ,
Follow us
Ìý
Ìý
Ìý
Ìý
Ìý
Ìý
Ìý